PURPOSE: Ensuring proper use of antimicrobials through the development and implementation of stewardship programs translates to improved patient outcomes. This article will describe the development of an antibiotic stewardship program at a facility with consultant-based infectious disease services. METHODS: Program development involved a multifaceted approach, including identification of a physician stewardship champion, design of a retrospective analysis, development of a physician scoring card, and creation and auditing of a real-time reporting system targeting prospective de-escalation opportunities. A seven-month retrospective chart analysis was performed on patients from two medical telemetry units with a diagnosis-related code for urinary tract infection to identify current prescribing practices of antimicrobials. The primary endpoint assessed the percentage of patients with missed opportunities for de-escalation. Secondary endpoints evaluated the impact on costs and hospital length of stay, comparing patients who were appropriately treated with those with missed de-escalation opportunities. RESULTS: Seventy-five patients were evaluated, 30 (40%) of whom were identified as having had missed opportunities for de-escalation. The cost of antibiotics for patients who were de-escalated averaged approximately $22.18 per day, compared with $70.26 per day (P = 0.04) for those with missed de-escalation opportunities. Patients receiving appropriate therapy had an average hospital length of stay of 6.42 days compared with 8.13 days for the missed-opportunity group (P = 0.052). CONCLUSION: The development of stewardship services at a consultant-based hospital is possible through a systematic approach, ultimately resulting in the expansion of available personnel and promotion of collaborative efforts.
PURPOSE: Ensuring proper use of antimicrobials through the development and implementation of stewardship programs translates to improved patient outcomes. This article will describe the development of an antibiotic stewardship program at a facility with consultant-based infectious disease services. METHODS: Program development involved a multifaceted approach, including identification of a physician stewardship champion, design of a retrospective analysis, development of a physician scoring card, and creation and auditing of a real-time reporting system targeting prospective de-escalation opportunities. A seven-month retrospective chart analysis was performed on patients from two medical telemetry units with a diagnosis-related code for urinary tract infection to identify current prescribing practices of antimicrobials. The primary endpoint assessed the percentage of patients with missed opportunities for de-escalation. Secondary endpoints evaluated the impact on costs and hospital length of stay, comparing patients who were appropriately treated with those with missed de-escalation opportunities. RESULTS: Seventy-five patients were evaluated, 30 (40%) of whom were identified as having had missed opportunities for de-escalation. The cost of antibiotics for patients who were de-escalated averaged approximately $22.18 per day, compared with $70.26 per day (P = 0.04) for those with missed de-escalation opportunities. Patients receiving appropriate therapy had an average hospital length of stay of 6.42 days compared with 8.13 days for the missed-opportunity group (P = 0.052). CONCLUSION: The development of stewardship services at a consultant-based hospital is possible through a systematic approach, ultimately resulting in the expansion of available personnel and promotion of collaborative efforts.
Entities:
Keywords:
antibiotic stewardship; consultant; de-escalation; program development; urinary tract infections
Authors: Lindsay E Nicolle; Suzanne Bradley; Richard Colgan; James C Rice; Anthony Schaeffer; Thomas M Hooton Journal: Clin Infect Dis Date: 2005-02-04 Impact factor: 9.079
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Shira Doron; Lauren Nadkarni; Lori Lyn Price; Pharmd Kenneth Lawrence; Lisa E Davidson; Jack Evans; Caren Garber; David R Snydman Journal: Clin Ther Date: 2013-06 Impact factor: 3.393
Authors: Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper Journal: Clin Infect Dis Date: 2011-03-01 Impact factor: 9.079